BPGbio advances potential first-ever treatment for primary CoQ10 deficiency (opens in new tab)

BPGbio presented clinical and translational findings for its investigational mitochondrial therapy BPM31510 at the United Mitochondrial Disease Foundation Mitochondrial Medicine Conference in Orlando, Florida, on 17 June 2026. The materials included an oral presentation and two posters reporting outcomes from four pediatric compassionate use subjects with genetically confirmed primary CoQ10 deficiency and preclinical studies in […] The post appeared first on <a href="